Molecules · 2016 · 11 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionHit-to-lead OptimizationLead Compound DesignLead DiscoveryTyrosine Kinase InhibitorsActivitiesColorimetric TestsEnzyme Kinetic AnalysisIsoxazole ChemistryMedicinal Chemistry ApplicationsProtein Tyrosine Phosphatase InhibitorsSelective Tyrosine Kinase InhibitorsSelectivity
By imitating the scaffold of lithocholic acid (LCA), a natural steroidal compound displaying Protein Tyrosine Phosphatase 1B (PTP1B) inhibitory activity, a series of stilbene derivatives containing phenyl-substituted isoxazoles were designed and synthesized. The structures of the title compounds were confirmed by 1H-NMR, 13C-NMR and HRMS. Activities of the title compounds were evaluated on PTP1B and the homologous enzyme TCPTP by using a colorimetric assay. Most of the target compounds had good activities against PTP1B. Among them, compound 29 (IC50 = 0.91 ± 0.33 μM), characterized by a 5-(2,3-dichlorophenyl) isoxazole moiety, exhibited an activity about 14-fold higher than the lead compound LCA and a 4.2-fold selectivity over TCPTP. Compound 29 was identified as a competitive inhibitor of PTP1B with a Ki value of 0.78 μM in enzyme kinetic studies.
20
Lori D. Klaman, Olivier Boss, Odile D. Peroni et al. · Molecular and Cellular Biology · 2000 · 1.2K citations
PTP1B Regulates Leptin Signal Transduction In Vivo
Janice M. Zabolotny, Kendra K. Bence, Alain Stricker‐Krongrad et al. · Developmental Cell · 2002 · 820 citations · Full text
Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B
Alan Cheng, Noriko Uetani, Paul D. Simoncic et al. · Developmental Cell · 2002 · 546 citations · Full text
OEstrogenic Activity of Certain Synthetic Compounds
E. C. Dodds, Leon I. Goldberg, W. Lawson et al. · Nature · 1938 · 507 citations